Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome-Reference-Cited by-同舟云学术

Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome

Published:2012-05-01 Issue:5 Volume:16 Page:596-603
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Keshavjee S.¹,Gelmanova I. Y.²,Shin S. S.³,Mishustin S. P.⁴,Andreev Y. G.⁵,Atwood S.⁶,Furin J. J.⁷,Miller A.⁸

Affiliation:

1. Program in Infectious Disease and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA; Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Partners In Health, Boston, Massachusetts, USA

2. Partners In Health, Boston, Massachusetts, USA

3. Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Partners In Health, Boston, Massachusetts, USA

4. Tomsk Oblast Tuberculosis Services, Tomsk, Russian Federation

5. Federal Penitentiary Services, Tomsk, Russian Federation

6. Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA

7. Case Western Reserve University, Cleveland, Ohio, USA

8. Program in Infectious Disease and Social Change, Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis;Indian Journal of Gastroenterology;2024-09-03

2. Comparative safety of bedaquiline and delamanid in patients with multidrug resistant tuberculosis: A nationwide retrospective cohort study;Journal of Microbiology, Immunology and Infection;2023-08

3. Protocol for a systematic review of long-term physical sequelae and financial burden of multidrug-resistant and extensively drug-resistant tuberculosis;PLOS ONE;2023-05-15

4. Prevalence of long-term physical sequelae among patients treated with multi-drug and extensively drug-resistant tuberculosis: a systematic review and meta-analysis;eClinicalMedicine;2023-03

5. Hepatocellular Injury in Children Treated for Rifampicin-resistant Tuberculosis: Incidence, Etiology and Outcome;Pediatric Infectious Disease Journal;2022-09-06